DelveInsight’s Diabetic Macular Edema Market Insights Report offers a detailed analysis of disease, its causes, symptoms, diagnostics modalities, and treatment options.
The Diabetic Macular Edema market report also offers comprehensive insights into Diabetic Macular Edema market size, epidemiology, emerging therapies, market drivers, market barriers, ongoing clinical trials, key collaboration in the space, and key pharmaceutical companies actively pushing the growth of Diabetic Macular Edema Market size forward.
Some of the key highlights from the Diabetic Macular Edema Market Insights:
- Germany had the highest number of Diabetic Macular Edema cases among the EU-4 countries.
- Diabetic Macular Edema appears to impact more males than females, according to secondary research findings.
- Major players such as Novartis, Genentech/Roche, Kodiak Sciences, Adverum Biotechnologies, Graybug Vision, Ocuphire Pharma, Oxurion, Allergan (AbbVie)/Molecular Partners, Unity Biotechnology, and others are involved in developing therapies for the treatment and management of Diabetic Macular Edema. These therapies are currently under different stages of development.
- Key pipeline therapies in the Diabetic Macular Edema market include Beovu (brolucizumab), Faricimab, KSI-301, ADVM-022, GB-102, APX3330, THR-149, Luminate (ALG-1001, Risuteganib), UBX1325, among others.
Learn more by requesting for sample @ Diabetic Macular Edema Market Landscape
Diabetic Macular Edema: Overview
Diabetic Retinopathy, a well-known consequence of diabetes, causes Diabetic Macular Edema. In both industrialized and developing nations, Diabetic Retinopathy is the most common diabetic eye condition and the major cause of permanent blindness in persons in their working years.
For more insights into Disease, causes, and treatment, reach out to Diabetic Macular Edema Treatment Landscape
Diabetic Macular Edema Epidemiology Segmentation
The Diabetic Macular Edema Market report proffers epidemiological analysis for the study period 2019-32 in the 7MM segmented into:
- Diabetic Macular Edema Prevalence
- Age-Specific Diabetic Macular Edema Prevalence
- Gender-Specific Diabetic Macular Edema Prevalence
- Diagnosed and Treatable Cases of Diabetic Macular Edema
Visit for more @ Diabetic Macular Edema Epidemiological Insights
Diabetic Macular Edema Market
The Diabetic Macular Edema market size is anticipated to increase during the study period, 2019–2032. The growth of the Diabetic Macular Edema market is expected to be mainly driven by increasing changes in lifestyle, addressing barriers to screening, increasing patient pool of diabetes, personalization of treatment and new pathways and novel approaches.
Diabetic Macular Edema Pipeline Therapies and Key Companies
- Beovu (brolucizumab): Novartis
- Faricimab: Genentech/Roche
- KSI-301: Kodiak Sciences
- ADVM-022: Adverum Biotechnologies
- GB-102: Graybug Vision
- APX3330: Ocuphire Pharma
- THR-149: Oxurion
- Luminate (ALG-1001, Risuteganib): Allergan (AbbVie)/Molecular Partners
- UBX1325: Unity Biotechnology
For more information, visit Diabetic Macular Edema Market Analysis, Patient Pool and Emerging Therapies
Diabetic Macular Edema Market Drivers
- Rising prevalent population
- Technological advancements
- Emerging therapies
- Extensive R&D
Scope of the Report
- 7MM Coverage
- Descriptive overview of Diabetic Macular Edema, covering causes, signs and symptoms, pathophysiology, diagnosis, and currently available therapies
- Comprehensive insight into Diabetic Macular Edema epidemiology and treatment in the 7MM
- Current and emerging therapies for Diabetic Macular Edema
- Diabetic Macular Edema market drivers and barriers
Table of Contents
|
1 |
Key Insights |
|
2 |
Report Introduction |
|
3 |
Competitive Intelligence Analysis for Diabetic Macular Edema |
|
4 |
Diabetic Macular Edema Market Overview at a Glance |
|
5 |
Executive Summary of Diabetic Macular Edema |
|
6 |
Diabetic Macular Edema Epidemiology and Market Methodology |
|
7 |
Diabetic Macular Edema Epidemiology and Patient Population |
|
8 |
Diabetic Macular Edema Patient Journey |
|
9 |
Treatment Algorithm, Current Treatment, and Medical Practices |
|
10 |
Key Endpoints in Diabetic Macular Edema Clinical Trials |
|
11 |
Diabetic Macular Edema Marketed Therapies |
|
12 |
Diabetic Macular Edema Emerging Therapies |
|
13 |
Diabetic Macular Edema: 7 Major Market Analysis |
|
14 |
Attribute analysis |
|
15 |
Access and Reimbursement Overview of Diabetic Macular Edema |
|
16 |
KOL Reviews |
|
17 |
Case Reports |
|
18 |
Diabetic Macular Edema Market Drivers |
|
19 |
Diabetic Macular Edema Market Barriers |
|
20 |
SWOT Analysis |
|
21 |
Disclaimer |
|
22 |
DelveInsight Capabilities |
|
23 |
About DelveInsight |
Related Reports:
Diabetic Macular Edema Epidemiology
Diabetic Macular Edema Pipeline
Latest Reports:
Intrahepatic Cholangiocarcinoma (ICCA) Market
COVID 19 Therapeutic Pipeline, Vaccines, and Diagnostics Competitive Landscape, 2020
Cervical Dysplasia Market
Agoraphobia Market
Hydrocephalus Market
Sarcopenia Market
Diabetic Kidney Disease Market
Acromegaly Market
Acute Respiratory Distress Syndrome (ARDS) Market
Acute Kidney Injury (AKI) Market
Renal Anemia Market
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences providing end-to-end comprehensive solutions to improve their performance.
Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/